JPRN-UMIN000003377已完成4 期
Evaluation of the suppressing effect of Telmisarten on aneurysm development in hypertensive aortic aneurysm patients - TELME study
Tohoku university hospital cardiovascular surgery0 个研究点目标入组 28 人开始时间: 2010年3月25日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 28
研究概览
简要总结
The trial was canceled due to difficulties in registering for the trial.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Taboo symptom of Telmisarten Pregnant women Liver and renal function failure Minority
研究者
相似试验
已完成
1 期
Clinical trial to evaluate the safety of Temsirolimus combined with Vincristine and Irinotecan in children with recurrent/refractory solid tumorschildhood recurrent/refractory solid malignant tumorsJPRN-UMIN000017453atural Center for Basic Research and Development, Hiroshima University3
已完成
1 期
Combination therapy with immune-cell therapy and immune check point inhibitor.malignant tumorJPRN-jRCTc031210185Takimoto Rishu3
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190100Takimoto Rishu40
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190098Takimoto Rishu40
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190099Takimoto Rishu40